Stay updated on Efficacy of Amifampridine in LEMS Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Amifampridine in LEMS Clinical Trial page.

Latest updates to the Efficacy of Amifampridine in LEMS Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision note updated to v3.4.2; the prior government funding notice (v3.4.1) and the related operating-status guidance were removed.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide government funding notice about potential delays and the NIH operating status, and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a glossary display and updated metadata items (Last Update Submitted that Met QC Criteria, No FEAR Act Data) and updated the revision from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check42 days agoChange DetectedFooter revision reference updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a dedicated Locations section with California as a listed location and removed the old California Locations heading. The HHS Vulnerability Disclosure link was removed and the page revision updated to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing the previous Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Efficacy of Amifampridine in LEMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Amifampridine in LEMS Clinical Trial page.